NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection | Zendy

Isaac See | Zendy; Yi Mu | Zendy; Jessica Cohen | Zendy; Zintars G. Beldavs | Zendy; Lisa G. Winston | Zendy; Ghinwa Dumyati | Zendy; Stacy Holzbauer | Zendy; Dori B. Reissman | Zendy; Monica M. Farley | Zendy; Carol A. Lyons | Zendy; Helen Johnston | Zendy; Erin C. Phipps | Zendy; Rebecca Perlmutter | Zendy; Lydia Anderson | Zendy; Dale N. Gerding | Zendy; Fernanda C. Lessa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection

Author(s) -

Isaac See,

Yi Mu,

Jessica Cohen,

Zintars G. Beldavs,

Lisa G. Winston,

Ghinwa Dumyati,

Stacy Holzbauer,

Dori B. Reissman,

Monica M. Farley,

Carol A. Lyons,

Helen Johnston,

Erin C. Phipps,

Rebecca Perlmutter,

Lydia Anderson,

Dale N. Gerding,

Fernanda C. Lessa

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu125

Subject(s) - medicine , clostridium difficile , toxic megacolon , pseudomembranous colitis , odds ratio , intensive care unit , population , confidence interval , colectomy , disease , gastroenterology , surgery , ulcerative colitis , microbiology and biotechnology , antibiotics , biology , environmental health

Studies are conflicting regarding the importance of the fluoroquinolone-resistant North American pulsed-field gel electrophoresis type 1 (NAP1) strain in Clostridium difficile infection (CDI) outcome. We describe strain types causing CDI and evaluate their association with patient outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research